Category: Retina Research
Dr. Roller Shares Insights on Gene Therapy and Vision Loss
Austin Retina Associates vitreoretinal specialist Dr. Aaron Brock Roller recently served as a resource for an article in Medical News Today about using gene therapy to treat vision loss. Gene therapy is an innovative technology that works by employing genetic material as therapy, like DNA or RNA, …
Read MoreParticipating in Clinical Research Trials at Austin Retina
Retina research has been instrumental in advancing exciting breakthroughs in retinal care for decades. Austin Retina has proudly participated in clinical trials that led to the FDA approval of almost every therapy used today. Our goal is to not only advance medical knowledge and shape the future of …
Read MoreImproving Sight Through Gene Therapy Research Studies
Gene therapy is a newer, innovative technology that is being researched as an effective treatment option for many medical conditions, including those affecting the retina and vision loss. At Austin Retina Associates, we are dedicated to advancing treatments that can help improve eyesight and …
Read MoreDr. Storey Shares Insight on GA and Diet
Age related macular degeneration (AMD) is a common disease of the retina affecting an estimated one in 10 Americans over the age of 50. Advanced AMD can result in geographic atrophy, which is characterized by loss of retinal tissue. Austin Retina Associates’ Dr. Philip Storey recently contributed …
Read MoreDr. Edward Wood Published in Leading Ophthalmology Journal
Austin Retina Associates’ very own Dr. Edward Wood recently had a paper published in the top ophthalmology journal – Progress in Retinal and Eye Research. The paper, “Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration,” explores how optogenetics can …
Read MoreRetina Care Highlights January 2023
Keep up with the latest retinal care and clinical research highlights from Austin Retina Associates. Case Report: Inherited Retinal Dystrophy This is a patient with an inherited retinal dystrophy (IRD) due to a genetic mutation. The retinal dystrophies are a group of rare diseases that cause …
Read MoreWhy Should I Participate in a Clinical Trial?
At Austin Retina Associates, we understand that there are a number of misconceptions patients may have about what it means to participate in a clinical trial. These misconceptions are unsurprising, as clinical trials, particularly modern ones, are not part of our normal, everyday conversations. We …
Read More